Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


Tesla Eyes $2.9 Billion in Chinese Solar Equipment to Power 100 GW U.S. Manufacturing Push
U.S. Appeals Court Strikes Down FTC Order Against TurboTax "Free" Advertising
FEMSA Cuts Jobs at Spin Fintech Unit, Refocuses Strategy on Oxxo Stores
Iran War Fears Send Oil Prices Surging as U.S. Weighs Ground Troop Deployment
Japan Eyes Reduction in Inflation-Linked Bond Buybacks Amid Surging Investor Demand
OpenAI's Desktop Superapp: Unifying ChatGPT, Codex, and Browser Tools for Enterprise AI
Asian Currencies Slide as Oil Prices Surge Amid U.S.-Israel-Iran Conflict
Iran Threatens Gulf Infrastructure as U.S.-Israel War Enters Critical 48-Hour Window
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit
Asian Markets Mixed as Oil Volatility and Inflation Fears Weigh on Sentiment
Oil Prices Hold Steady Amid Middle East Escalation and Sanctions Relief
Trump Issues 48-Hour Ultimatum to Iran Over Strait of Hormuz, Threatens Power Grid Strikes
South Korean Stocks Tumble as Hawkish BOK Governor Appointment Rattles Markets
Israel Defies Trump's Warning, Launches New Strikes on Iran Amid Growing Global Energy Crisis
Amazon's "Transformer" Phone: Can It Succeed Where Fire Phone Failed?
Goldman Sachs Delays Bank of England Rate Cut Forecast Amid Middle East Inflation Risks
Global Markets Tumble as US-Iran Tensions Escalate, Oil Surges 



